Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Hemorrhagic Fevers
by Most Patent Filings in the world in 2022

The Hemorrhagic Fevers top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filings Hemorrhagic Fevers Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Viral hemorrhagic fevers (VHFs) are a group of illnesses caused by four families of viruses. These include the Ebola and Marburg, Lassa fever, and yellow fever viruses. VHFs have common features: they affect many organs, they damage the blood vessels, and they affect the body's ability to regulate itself. Some VHFs cause mild disease, but some, like Ebola or Marburg, cause severe disease and death.

VHFs are found around the world. Specific diseases are usually limited to areas where the animals that carry them live. For example, Lassa fever is limited to rural areas of West Africa where rats and mice carry the virus.

The risk for travelers is low, but you should avoid visiting areas where there are disease outbreaks. Because there are no effective treatments for some of these viral infections, there is concern about their use in bioterrorism.

Centers for Disease Control and Prevention

#
Company Name
Region
Tech Topics
Total
1
Patent: 29
2
Scrub typhus,Leptospira,Murine typhus,
...[+2]
Patent: 7
3
Biotechnology,Pharmaceutics,Shopping mall,
...[+2]
Patent: 6
4
Patent: 5
5
Patent: 4
6
Medicine,Health care,Amino acid,
...[+2]
Patent: 3
7
Sweden
Patent: 3
8
Kyoto, Japan
Patent: 3
9
Patent: 3
10
Medical research,Critical area,Battlefield,
...[+1]
Patent: 3
11
BV, DE
Patent: 3
12
Patent: 2
13
Patent: 2
14
Patent: 2
15
Oncology,Health care,Monoclonal antibody,
...[+2]
Patent: 2
16
Patent: 2
17
Pharmacy and Therapeutics,Medicine,Staphylococcal infections,
...[+2]
Patent: 2
18
Thüringen, Germany
Health care,Clinical trial,Drug resistance,
...[+2]
Patent: 2
19
Patent: 2
20
Tokyo, Japan
Patent: 1
Page generation time: May 16 2025